Objective: To investigate the
application of cystatin C combined with homocysteine detection in AIDS and
tuberculosis complicated with hypertension. Methods: 57 patients with
AIDS complicated with hypertension and 52 patients with tuberculosis
complicated with hypertension from Guangxi Infectious Diseases Hospital Nanning
Fourth People’s Hospital/Guangxi AIDS Clinical Treatment Center (Nanning) from
October 2022 to March 2023, and 196 patients with simple hypertension from
Guangxi Cardiovascular Diseases Hospital Nanning Third People’s Hospital were
selected as research objects. And then the difference in the detection results
of cystatin C and homocysteine among the three groups was compared. Results: The detection results of serum cystatin C and homocysteine in AIDS patients
with hypertension and tuberculosis patients with hypertension were higher than
those in the simple hypertension group, and
the difference was statistically significant (P < 0.05). However,
there was no significant difference in the detection results of cystatin C or
homocysteine between the AIDS hypertension group and the tuberculosis
hypertension group (P > 0.05). Conclusion: The detection of cystatin
C combined with homocysteine has high clinical application value in AIDS with
hypertension and tuberculosis with hypertension. When AIDS is combined with
hypertension or tuberculosis is combined with hypertension, cystatin C and
homocysteine are at a high level, while the concentration levels of cystatin C
and homocysteine are relatively low in simple hypertension. Therefore, cystatin
C combined with homocysteine detection can provide better laboratory evidence
for clinical diagnosis and differential diagnosis, and is worth promoting and
applying.
References
[1]
Yang, J., Tan, W. and Yang, Y.Y. (2015) Study on the Therapeutic Effect of Rational Use of Antihypertensive Drugs in AIDS Patients with Hypertension. Contemporary Medicine, 21, 142-143.
[2]
Feng, X.Y., Chen, Y.Y., Wang, X., et al. (2020) Analysis of Antituberculosis Drug Tolerance in Elderly Patients with Pulmonary Tuberculosis Complicated with Hypertension. Medical Dietary Therapy and Health, 18, Article ID: 103105.
[3]
Zheng, Y. (2021) Study on the Effect of Rifampicin on Antihypertensive Drugs in Patients with Pulmonary Tuberculosis and Hypertension. Dietary Health, No. 18, 98.
[4]
Chen, T. (2021) The Clinical Value of Serum Cystatin C Combined with Homocysteine Detection in the Diagnosis of Hypertensive Early Nephropathy. Chinese Journal of Practical Medicine, 16, 14-16.
[5]
Zhang, X.M. and Yang, J.P. (2021) Clinical Significance of Combined Detection of Serum Adiponectin, Cystatin C, and Homocysteine in Patients with Hypertensive Renal Damage. Chinese Medical Science, 11, 147-151.
[6]
Huangfu, B.B., Chen, X.Y. and Lu, F.R. (2021) Effects of Levofloxacin and Pyrazinamide on Renal Function and Adverse Reactions in Elderly Patients with Pulmonary Tuberculosis and Hypertension. Chinese Contemporary Medicine, 28, 77-79, 86.
[7]
Duan, Y. (2019) Clinical Efficacy of Digoxin Combined with Captopril in the Treatment of Elderly Hypertension with Heart Failure. Senior Doctor, 4, 115-116.
[8]
Xu, J. and Luo, Y.R. (2020) Analysis of the Application Effect of High-Quality Nursing in Elderly Patients with Secondary Pulmonary Tuberculosis and Hypertension. Chinese Journal of Metallurgical Industry Medicine, 37, 588.
[9]
Wang, X.H., Yang, H.J., Hu, X.H., et al. (2021) Clinical Significance of Serum Cystatin C Combined with Homocysteine Detection for Early Hypertensive Nephropathy. Chinese Journal of Clinicians, 49, 63-65.
[10]
Zhang, L.P., Chen, L. and Zhong, A.H. (2022) Analysis of the Value of Carotid Color Doppler Combined with hs-CRP, Hcy, and CysC Detection in the Diagnosis of Hypertensive Heart Disease. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine, 22, 80-83.
[11]
Huang, H.C., Ke, X., Xie, G.S., et al. (2021) Study on the Value of Combined Detection of SysC and Hcy in the Diagnosis of Elderly Hypertensive Nephropathy. Chinese Medical Science, 11, 163-166.
[12]
Zhang, G.Y. and Zhang, Q.S. (2019) Diagnostic Value of Serum Homocysteine and Cystatin C in Early Renal Injury in Hypertension. Modern Practical Medicine, 31, 44-45.
[13]
Liu, Z.L., Pu, R., Liu, X., et al. (2019) The Value of Combined Detection of Cystatin C, Homocysteine, and Urinary Microalbumin/Creatinine Ratio in the Diagnosis of Early Renal Damage in Hypertension. Modern Medicine and Hygiene, 35, 1011-1013.
[14]
Li, T., Wu, S.Y. and Su, F. (2020) Clinical Observation of Zhenju Jiangya Tablet Combined with Nifedipine Sustained-Release Tablets in the Treatment of Essential Hypertension and Its Effect on Vascular Endothelial Function, Cystatin C, Homocysteine, and Hypersensitive C-Reactive Protein Levels. China Grassroots Medicine, 27, 2895-2899.
[15]
Li, L. (2019) The Diagnostic Value of Combined Detection of Serum Cystatin C and Homocysteine for Early Renal Injury in Hypertension. Laboratory Medicine and Clinical, 16, 1558-1560.
[16]
Zhou, X.P. and Lei, G.P. (2019) The Diagnostic Value of Combined Detection of CysC and Hcy in Early Renal Damage in Hypertension. Clinical Medical Research and Practice, 4, 97-98.
[17]
Zhu, S.J. (2019) Clinical Significance of Serum Cys C Combined with Hcy Detection in Evaluating Early Renal Damage in Patients with Hypertension. Henan Medical Research, 28, 906-907.
[18]
Luo, Y., Zhang, Y.P., Qiu, C.H., et al. (2020) Application of Combined Detection of U-mALB Combined with Whole Blood hs-CRP, Serum CysC, and Serum Hcy in the Early Diagnosis of Hypertensive Nephropathy. Journal of Laboratory Medicine and Clinical Medicine, 17, 174-177, 182.
[19]
Guo, Z.G. and Hu, F.Y. (2020) Application Value of the Combined Detection of Cys C, UAER, β2-MG and Hcy in Early Renal Injury in Elderly Patients with Hypertension. Modern Practical Medicine, 32, 1283-1285.
[20]
Fan, Z.H., Lin, N., Chen, W.J., et al. (2019) The Value of the Detection of Neck Vascular Color Doppler Ultrasound Combined with Serum hs-CRP, Hcy, and CysC in the Diagnosis of Hypertensive Heart Disease. Chinese Journal of Gerontology, 39, 1299-1301.
[21]
Zou, L., Yan, Z.M. and Zhang, L. (2019) The Effect of Losartan Potassium Hydrochlorothiazide Combined with Folic Acid Tablets on Blood Pressure Control and Changes in Serum Hcy and CysC Levels in Patients with Type H Hypertension. China Practical Medicine, 14, 13-15.
[22]
Zhang, Y.W. and Luo, M.Q. (2019) Clinical Value Analysis of Detection of Hcy, CysC, and U-mALB in the Diagnosis of Early Renal Injury in Elderly Patients with Hypertension. Modern Diagnosis and Treatment, 30, 3215-3217.
[23]
Hou, S.Z. (2020) Effect of Folic Acid Combined with Rosuvastatin on Serum Uric Acid and CysC Levels in Patients with Essential Hypertension. Clinical Medicine, 40, 91-93.
[24]
Han, M. (2020) Study on the Correlation between Serum Hcy, UA, Cyst-C and Left Ventricular Hypertrophy in Elderly Patients with Essential Hypertension. Shanxi Medical University, Taiyuan.
